Global Stem Cells Group has announced the opening of a new stem cell clinic in Quito, Ecuador. The new facility will offer the latest stem cell and regenerative medicine treatments for orthopedic and trauma applications.
MIAMI, Feb. 11, 2016—Global Stem Cells Group, has announced the opening of its new stem cell treatment clinic in Quito, Ecuador. The new facility will provide advanced protocols and state-of-the-art techniques in cellular medicine, focusing on orthopedic and trauma applications to patients from around the world.
The new GSCG clinic is headed by four prominent Ecuadorian physicians, including Pablo Ramos, M.D. an orthopedic specialist and attending physician at Metropolitan Hospital in Quito; Pablo Cornejo, M.D., a specialist in orthopedic and trauma surgery at Metropolitan Hospital, Quito; Luis Ernesto Mantilla, M.D., a specialist in trauma and knee Surgery,at Metropolitan Hospital, Quito, and Pablo Ramos, M.D., a specialist in trauma surgery and arthroscopy at Metropolitan Hospital, Quito.
The opening of the Quito stem cell clinic marks Global Stem Cells Group’s first facility in Ecuador, and is part of GSCG’s expanding presence in Latin America.
Global Stem Cells Group has been expanding its clinical presence worldwide by partnering with qualified physicians experienced in stem cell therapies to open new clinics, licensed and developed under the GSCG banner.
Global Stem Cells Group provides stem cell treatments for a variety of conditions and diseases including arthritis, autism, chronic obstructive pulmonary disease (COPD), diabetes, multiple sclerosis, injuries and more at various facilities worldwide. The new facility in Quito will have an international staff that is experienced in administering the leading cellular therapies available.
Global Stem Cells Group’s Quito clinic is certified for the medical tourism market, and staff physicians are board-certified or board-eligible. GSCG clinics provide services in more than 10 specialties, attracting patients from the United States and around the world.
For more information, visit the Global Stem Cells Group website, email bnovas(at)stemcellsgroup(dot)com, or call +1 305 560 5337.
About the Global Stem Cell Group:
Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions. With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.
Global Stem Cells Group’s corporate mission is to make the promise of stem cell medicine a reality for patients around the world. With each of GSCG’s six operating companies focused on a separate research-based mission, the result is a global network of state-of-the-art stem cell treatments.
To view this press release live online, click here